High-Grade Extremity Soft Tissue Sarcomas: Factors Predictive of Local Recurrence and Its Effect on Morbidity and Mortality

Annals of Surgery

Volumn 237, Issue 2, 2003, Pages 218-226

  Eilber, Fritz C ^a   Rosen, Gerald ^a   Nelson, Scott D ^a   Selch, Michael ^a   Dorey, Frederick ^a   Eckardt, Jeffery ^a   Eilber, Frederick R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMPUTATION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SURGICAL APPROACH; TREATMENT OUTCOME; TUMOR VOLUME; ADJUVANT THERAPY; CLINICAL PROTOCOL; LIMB; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RADIOTHERAPY; RISK FACTOR; SARCOMA; SURVIVAL; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENT; DOXORUBICIN; IFOSFAMIDE; PLATINUM;

AMPUTATION; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC PROTOCOLS; COMBINED MODALITY THERAPY; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; LIMB SALVAGE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PLATINUM; PROGNOSIS; RADIOTHERAPY; RISK FACTORS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037315695     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200302000-00011     Document Type: Article

References (27)

1. Morton DL, Eilber FR, Townsend CM, et al. Limb salvage from a multidisciplinary treatment approach for skeletal and soft tissue sarcomas of the extremity. Ann Surg 1976; 184:268-278.
2. Eilber FR, Mirra JJ, Grant TT, et al. Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg 1980; 192:431-438.
3. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcoma of the extremities: Prospective randomized evaluation of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982; 196:305-315.
4. Williard WC, Hajdu SI, Casper ES, et al. Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann Surg 1992; 215:269-275.
5. Brennan MF, Hilaris B, Shiu MH, et al. Local recurrence in adult soft tissue sarcoma. A randomized trial of brachytherapy. Arch Srug 1987; 122:1289-1293.
6. Harrison LB, Franzese F, Gaynor JJ, et al. Long term results of a prospective trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993; 27:259-265.
7. Pisters PWT, Harrison LB, Leung DHT, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996; 14:859-868.
8. Brennan MF, Casper ES, Harrison LB, et al. The role of multimodality therapy in soft tissue sarcoma. Ann Surg 1991; 214:328-338.
9. Potter DA, Kinsella T, Glatstein E, et al. High-grade soft tissue sarcomas of the extremities. Cancer 1986; 58:190-205.
10. Gustafson P, Rooser B, Rydholm A. Is local recurrence of minor importance for metastese in soft tissue sarcoma? Cancer 1991; 67: 2083-2086.
11. Singer S, Corson JM, Gonin R, et al. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 1994; 219:165-173.
12. Karakousis CP, Proimakis C, Rao U, et al. Local recurrence and survival in soft-tissue sarcomas. Ann Surg Oncol 1995; 3:255-260.
13. Stotter AT, Ahern RP, Fisher C, et al. The influence of local recurrence of extremity soft tissue sarcoma on metastases and survival. Cancer 1990; 65:1119-1129.
14. Lewis JJ, Leung D, Heslin M, et al. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol 1997; 15:646-652.
15. Hajdu SI, Shiu MH, Brennan MF. The role of the pathologist in the management of soft tissue sarcomas. World J Surg 1988; 12:326-331.
16. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16(3):1141-1154.
17. Tai B, Machin D, White I, et al. Competing risk analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med 2001; 20(5):661-684.
18. Kalbfleisch EL, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sones 1980; 122-126.
19. Huth JF, Eilber FR. Patterns of metastatic spread following resection of extremity soft tissue sarcomas and strategies for treatment. Semin Surg Oncol 1988; 4:20-26.
20. Giuliano AE, Eilber FR, Morton DL. The management of locally recurrent soft-tissue sarcoma. Ann Surg 1982; 196:87-91.
21. Pisters PWT, Leung DHY, Woodruff J, et al. Analysis of prognostice factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14:1679-1689.
22. Coindre J, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the french federation of cancer centers sarcoma group. J Clin Oncol 1996; 14:869-877.
23. Lewis JJ, Leung D, Casper ES, et al. Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg 1999; 134:190-194.
24. Eilber FC, Rosen G, Eckardt J, et al. Treatment induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high grade extremity soft tissue sarcomas. J Clin Oncol 2001; 19:3203-3209.
25. Pisters PW. Chemoradiation treatment strategies for localized sarcoma: conventional and investigational approaches. Semin Surg Oncol 1999; 17:66-71.
26. Patel SR, Benjamin RS. New chemotherapeutic strategies for soft tissue sarcomas. Semin Surg Oncol 1999; 17:47-51.
27. Benjamin RS. Evidence for using adjuvant chemotherapy as standard treatment of soft tissue sarcomas. Semin Radiat Oncol 1999; 9:349-351.